ID

26305

Beskrivning

Combination Therapy With MYOCET® (Doxorubicin HCL Liposome for Injection) in Patients With HER2-Positive Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00712881

Länk

https://clinicaltrials.gov/show/NCT00712881

Nyckelord

Versioner (1)
  1. 2017-10-16 2017-10-16 -
Rättsinnehavare

See clinicaltrials.gov

Uppladdad den

16 oktober 2017

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Breast Cancer NCT00712881

Engelsk

Eligibility Breast Cancer NCT00712881

1 Formulär  
Criteria
Beskrivning

Criteria

treatment-naive patients with stage ii or iii invasive breast cancer (proven histologically/cytologically) and with tests showing an overexpressing of human epidermal growth factor receptor 2 (her2).
Beskrivning

Therapy naive | Invasive carcinoma of breast TNM Breast tumor staging | erbB-2 Receptor Overexpression Tests

Datatyp

boolean

Alias
UMLS CUI [1]
C0919936
UMLS CUI [2,1]
C0853879
UMLS CUI [2,2]
C0474926
UMLS CUI [3,1]
C0069515
UMLS CUI [3,2]
C1514559
UMLS CUI [3,3]
C0022885
patients have at least one bidimensionally measurable lesion according to the who criteria.
Beskrivning

Measurable lesion 2-Dimensional Quantity

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1513041
UMLS CUI [1,2]
C1705052
UMLS CUI [1,3]
C1265611
the patient has an eastern cooperative oncology group (ecog) performance status of 0 or 1.
Beskrivning

ECOG performance status

Datatyp

boolean

Alias
UMLS CUI [1]
C1520224
the patient has an lvef of at least 55% as assessed by multiple-gated acquisition (muga) scan (preferred) or echocardiography.
Beskrivning

Left ventricular ejection fraction Multiple gated acquisition scanning | Left ventricular ejection fraction Echocardiography

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0428772
UMLS CUI [1,2]
C0521317
UMLS CUI [2,1]
C0428772
UMLS CUI [2,2]
C0013516
the patient has hematology and serum chemistry laboratory test results within specific protocol-defined ranges.
Beskrivning

Hematology finding | Serum Chemistry Measurement

Datatyp

boolean

Alias
UMLS CUI [1]
C0474523
UMLS CUI [2]
C1883010
women of childbearing potential must use a medically accepted method of contraception and must agree to continue use of this method for the duration of the treatment period and for 6 months after the last administration of study drug.
Beskrivning

Childbearing Potential Contraceptive methods

Datatyp

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0700589
main exclusion criteria:
Beskrivning

Exclusion Criteria Main

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0680251
UMLS CUI [1,2]
C1542147
the patient:
Beskrivning

Client Characteristics

Datatyp

boolean

Alias
UMLS CUI [1]
C0815172
has received previous cancer therapy for breast cancer.
Beskrivning

Cancer treatment Breast Carcinoma

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0920425
UMLS CUI [1,2]
C0678222
has any history of chf, angina pectoris, or myocardial infarction.
Beskrivning

Congestive heart failure | Angina Pectoris | Myocardial Infarction

Datatyp

boolean

Alias
UMLS CUI [1]
C0018802
UMLS CUI [2]
C0002962
UMLS CUI [3]
C0027051
has uncontrolled hypertension.
Beskrivning

Uncontrolled hypertension

Datatyp

boolean

Alias
UMLS CUI [1]
C1868885
has infection, peptic ulcer, or unstable diabetes mellitus.
Beskrivning

Communicable Disease | Peptic Ulcer | Brittle diabetes

Datatyp

boolean

Alias
UMLS CUI [1]
C0009450
UMLS CUI [2]
C0030920
UMLS CUI [3]
C0342302
has been treated with live virus vaccines within 8 weeks before the first administration of study drug.
Beskrivning

Vaccines, Attenuated

Datatyp

boolean

Alias
UMLS CUI [1]
C0042211
has impaired hepatic or renal function.
Beskrivning

Liver Dysfunction | Renal Insufficiency

Datatyp

boolean

Alias
UMLS CUI [1]
C0086565
UMLS CUI [2]
C1565489
is a pregnant or lactating woman. (any women becoming pregnant during the study will be withdrawn from the study.)
Beskrivning

Pregnancy | Breast Feeding

Datatyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
has used an investigational drug within one month before the screening visit.
Beskrivning

Investigational New Drugs

Datatyp

boolean

Alias
UMLS CUI [1]
C0013230
has a known hypersensitivity to any of the study drugs or to their active ingredients.
Beskrivning

Hypersensitivity Investigational New Drugs | Hypersensitivity Investigational New Drugs Active ingredient

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0013230
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0013230
UMLS CUI [2,3]
C1372955
has an inflammatory breast cancer.
Beskrivning

Inflammatory Breast Carcinoma

Datatyp

boolean

Alias
UMLS CUI [1]
C0278601
has had any other malignancies within five years (except for adequately treated carcinoma in situ of the cervix or basal or squamous cell skin cancer).
Beskrivning

Malignant Neoplasms | Exception Carcinoma in situ of uterine cervix Treated | Exception Basal cell carcinoma Treated | Exception Squamous cell carcinoma of skin Treated

Datatyp

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0851140
UMLS CUI [2,3]
C1522326
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0007117
UMLS CUI [3,3]
C1522326
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0553723
UMLS CUI [4,3]
C1522326
Tillbaka till toppen

Similar models

Eligibility Breast Cancer NCT00712881

1 Formulär
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
Therapy naive | Invasive carcinoma of breast TNM Breast tumor staging | erbB-2 Receptor Overexpression Tests
Item
treatment-naive patients with stage ii or iii invasive breast cancer (proven histologically/cytologically) and with tests showing an overexpressing of human epidermal growth factor receptor 2 (her2).
boolean
C0919936 (UMLS CUI [1])
C0853879 (UMLS CUI [2,1])
C0474926 (UMLS CUI [2,2])
C0069515 (UMLS CUI [3,1])
C1514559 (UMLS CUI [3,2])
C0022885 (UMLS CUI [3,3])
Measurable lesion 2-Dimensional Quantity
Item
patients have at least one bidimensionally measurable lesion according to the who criteria.
boolean
C1513041 (UMLS CUI [1,1])
C1705052 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
ECOG performance status
Item
the patient has an eastern cooperative oncology group (ecog) performance status of 0 or 1.
boolean
C1520224 (UMLS CUI [1])
Left ventricular ejection fraction Multiple gated acquisition scanning | Left ventricular ejection fraction Echocardiography
Item
the patient has an lvef of at least 55% as assessed by multiple-gated acquisition (muga) scan (preferred) or echocardiography.
boolean
C0428772 (UMLS CUI [1,1])
C0521317 (UMLS CUI [1,2])
C0428772 (UMLS CUI [2,1])
C0013516 (UMLS CUI [2,2])
Hematology finding | Serum Chemistry Measurement
Item
the patient has hematology and serum chemistry laboratory test results within specific protocol-defined ranges.
boolean
C0474523 (UMLS CUI [1])
C1883010 (UMLS CUI [2])
Childbearing Potential Contraceptive methods
Item
women of childbearing potential must use a medically accepted method of contraception and must agree to continue use of this method for the duration of the treatment period and for 6 months after the last administration of study drug.
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
Exclusion Criteria Main
Item
main exclusion criteria:
boolean
C0680251 (UMLS CUI [1,1])
C1542147 (UMLS CUI [1,2])
Client Characteristics
Item
the patient:
boolean
C0815172 (UMLS CUI [1])
Cancer treatment Breast Carcinoma
Item
has received previous cancer therapy for breast cancer.
boolean
C0920425 (UMLS CUI [1,1])
C0678222 (UMLS CUI [1,2])
Congestive heart failure | Angina Pectoris | Myocardial Infarction
Item
has any history of chf, angina pectoris, or myocardial infarction.
boolean
C0018802 (UMLS CUI [1])
C0002962 (UMLS CUI [2])
C0027051 (UMLS CUI [3])
Uncontrolled hypertension
Item
has uncontrolled hypertension.
boolean
C1868885 (UMLS CUI [1])
Communicable Disease | Peptic Ulcer | Brittle diabetes
Item
has infection, peptic ulcer, or unstable diabetes mellitus.
boolean
C0009450 (UMLS CUI [1])
C0030920 (UMLS CUI [2])
C0342302 (UMLS CUI [3])
Vaccines, Attenuated
Item
has been treated with live virus vaccines within 8 weeks before the first administration of study drug.
boolean
C0042211 (UMLS CUI [1])
Liver Dysfunction | Renal Insufficiency
Item
has impaired hepatic or renal function.
boolean
C0086565 (UMLS CUI [1])
C1565489 (UMLS CUI [2])
Pregnancy | Breast Feeding
Item
is a pregnant or lactating woman. (any women becoming pregnant during the study will be withdrawn from the study.)
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Investigational New Drugs
Item
has used an investigational drug within one month before the screening visit.
boolean
C0013230 (UMLS CUI [1])
Hypersensitivity Investigational New Drugs | Hypersensitivity Investigational New Drugs Active ingredient
Item
has a known hypersensitivity to any of the study drugs or to their active ingredients.
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0013230 (UMLS CUI [2,2])
C1372955 (UMLS CUI [2,3])
Inflammatory Breast Carcinoma
Item
has an inflammatory breast cancer.
boolean
C0278601 (UMLS CUI [1])
Malignant Neoplasms | Exception Carcinoma in situ of uterine cervix Treated | Exception Basal cell carcinoma Treated | Exception Squamous cell carcinoma of skin Treated
Item
has had any other malignancies within five years (except for adequately treated carcinoma in situ of the cervix or basal or squamous cell skin cancer).
boolean
C0006826 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0851140 (UMLS CUI [2,2])
C1522326 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C0007117 (UMLS CUI [3,2])
C1522326 (UMLS CUI [3,3])
C1705847 (UMLS CUI [4,1])
C0553723 (UMLS CUI [4,2])
C1522326 (UMLS CUI [4,3])
Tillbaka till toppen 

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial